Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | November 02, 2018 | February 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date November 02, 2018 · Filed February 14, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 217,385 |
Reported balance
After 2018-11-02 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2018-11-02 · Grant · Acquired 217,385 · Balance 217,385 F1: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. This Form 4A is being filed to correctly reflect the beneficial ownership of shares held directly and indirectly by Mr. Spencer, which the original Form 4 misstated. |
| Common Stock Class ASEC Table I · non-derivative | IndirectBy Firm | 2,790,545 |
Reported balance
After 2018-11-02 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2018-11-02 · Grant · Acquired 2,790,545 · Balance 2,790,545 F1: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. This Form 4A is being filed to correctly reflect the beneficial ownership of shares held directly and indirectly by Mr. Spencer, which the original Form 4 misstated. |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Spouse | 2,353 |
Reported balance
After 2018-11-02 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2018-11-02 · Grant · Acquired 2,353 · Balance 2,353 F1: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. This Form 4A is being filed to correctly reflect the beneficial ownership of shares held directly and indirectly by Mr. Spencer, which the original Form 4 misstated. |
Filing footnotes · ownership attribution and instrument terms
F1: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. This Form 4A is being filed to correctly reflect the beneficial ownership of shares held directly and indirectly by Mr. Spencer, which the original Form 4 misstated.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2018 Filed Nov 6, 2018 23:36 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,020,690 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001156375-18-000131 · primary_doc.xml · nonDerivative · entry 1 Spencer Michael A · CIK 0001757667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,020,690 F1 · price: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. Immediately prior to the effective date of the Acquisition and the exchange of shares, Mr. Spencer held 68,033,572 shares of NEX. Read SEC document |
| November 02, 2018 Filed Feb 14, 2019 17:19 UTC Amendment | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000006 · edgardoc.xml · nonDerivative · entry 3 Spencer Michael A · CIK 0001757667 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 2,353 F1 · shares: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. This Form 4A is being filed to correctly reflect the beneficial ownership of shares held directly and indirectly by Mr. Spencer, which the original Form 4 misstated. Read SEC document |
| November 02, 2018 Filed Feb 14, 2019 17:19 UTC Amendment | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,790,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000006 · edgardoc.xml · nonDerivative · entry 2 Spencer Michael A · CIK 0001757667 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 2,790,545 F1 · shares: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. This Form 4A is being filed to correctly reflect the beneficial ownership of shares held directly and indirectly by Mr. Spencer, which the original Form 4 misstated. Read SEC document |
| November 02, 2018 Filed Feb 14, 2019 17:19 UTC Amendment | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 217,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000006 · edgardoc.xml · nonDerivative · entry 1 Spencer Michael A · CIK 0001757667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,385 F1 · shares: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. This Form 4A is being filed to correctly reflect the beneficial ownership of shares held directly and indirectly by Mr. Spencer, which the original Form 4 misstated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.